Werkgroep Cardiologische centra Nederland

SPIRE-LL (Completed)

STUDY TO ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF PF-04950615 IN SUBJECTS WITH PRIMARY HYPERLIPIDEMIA OR MIXED DYSLIPIDEMIA AT RISK OF CARDIOVASCULAR EVENTS
Medicine
PF-04950615 (PCSK9)
Population
Primairy prevention cardiovasular disease
Phase
III
Starting year
2014
More information
clinicaltrials.gov

Director of Study

dr. B.E. Groenemeijer (Cardioloog)
Apeldoorn, Gelre Ziekenhuizen